243 related articles for article (PubMed ID: 22734839)
21. Bioactivation of tamoxifen by recombinant human cytochrome p450 enzymes.
Notley LM; De Wolf CJ; Wunsch RM; Lancaster RG; Gillam EM
Chem Res Toxicol; 2002 May; 15(5):614-22. PubMed ID: 12018981
[TBL] [Abstract][Full Text] [Related]
22. Induced expression of cytochrome P450 1A and NAD(P)H:quinone oxidoreductase determined at mRNA, protein, and enzyme activity levels in rats exposed to the carcinogenic azo dye 1-phenylazo-2-naphthol (Sudan I).
Stiborová M; Dračínská H; Martínek V; Svášková D; Hodek P; Milichovský J; Hejduková Ž; Brotánek J; Schmeiser HH; Frei E
Chem Res Toxicol; 2013 Feb; 26(2):290-9. PubMed ID: 23289503
[TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics simulation studies for DNA sequence recognition by reactive metabolites of anticancer compounds.
Tumbi KM; Nandekar PP; Shaikh N; Kesharwani SS; Sangamwar AT
J Mol Recognit; 2014 Mar; 27(3):138-50. PubMed ID: 24446378
[TBL] [Abstract][Full Text] [Related]
24. A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid
Fekry MI; Xiao Y; Berg JZ; Guengerich FP
Drug Metab Dispos; 2019 Nov; 47(11):1325-1332. PubMed ID: 31511258
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic analysis and identification of a role for the orphan human cytochrome P450 2W1 in selective oxidation of lysophospholipids.
Xiao Y; Guengerich FP
J Lipid Res; 2012 Aug; 53(8):1610-7. PubMed ID: 22591743
[TBL] [Abstract][Full Text] [Related]
26. Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5-fluoro-benzothiazole: a potential surrogate marker for patient sensitivity.
Hose CD; Hollingshead M; Sausville EA; Monks A
Mol Cancer Ther; 2003 Dec; 2(12):1265-72. PubMed ID: 14707267
[TBL] [Abstract][Full Text] [Related]
27. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
[TBL] [Abstract][Full Text] [Related]
28. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
[TBL] [Abstract][Full Text] [Related]
29. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s.
Wen B; Ma L; Zhu M
Chem Biol Interact; 2008 May; 173(1):59-67. PubMed ID: 18359012
[TBL] [Abstract][Full Text] [Related]
30. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
Marill J; Cresteil T; Lanotte M; Chabot GG
Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
[TBL] [Abstract][Full Text] [Related]
31. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles.
Hutchinson I; Chua MS; Browne HL; Trapani V; Bradshaw TD; Westwell AD; Stevens MF
J Med Chem; 2001 Apr; 44(9):1446-55. PubMed ID: 11311068
[TBL] [Abstract][Full Text] [Related]
32. Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.
Schneider KJ; DeCaprio AP
Chem Res Toxicol; 2013 Nov; 26(11):1755-64. PubMed ID: 24112049
[TBL] [Abstract][Full Text] [Related]
33. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
34. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
[TBL] [Abstract][Full Text] [Related]
35. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
[TBL] [Abstract][Full Text] [Related]
36. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation.
Kleiner HE; Vulimiri SV; Reed MJ; Uberecken A; DiGiovanni J
Chem Res Toxicol; 2002 Feb; 15(2):226-35. PubMed ID: 11849049
[TBL] [Abstract][Full Text] [Related]
37. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
Wen B; Chen Y; Fitch WL
Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
[TBL] [Abstract][Full Text] [Related]
38. Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5.
Stiborová M; Poljaková J; Martínková E; Ulrichová J; Simánek V; Dvořák Z; Frei E
Toxicology; 2012 Dec; 302(2-3):233-41. PubMed ID: 22917556
[TBL] [Abstract][Full Text] [Related]
39. Comparison of in vitro bioactivation of flutamide and its cyano analogue: evidence for reductive activation by human NADPH:cytochrome P450 reductase.
Wen B; Coe KJ; Rademacher P; Fitch WL; Monshouwer M; Nelson SD
Chem Res Toxicol; 2008 Dec; 21(12):2393-406. PubMed ID: 19548358
[TBL] [Abstract][Full Text] [Related]
40. Comparative metabolism of the aza polynuclear aromatic hydrocarbon dibenz[a,h]acridine by recombinant human and rat cytochrome P450s.
Yuan ZX; Kumar S; Sikka HC
Chem Res Toxicol; 2004 May; 17(5):672-8. PubMed ID: 15144224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
